Hepatitis E in Scotland: Assessment of HEV infection in two high-risk patient groups with elevated liver enzymes

Journal of Clinical Virology

Volumn 63, Issue , 2015, Pages 36-37

  Bradley Stewart, A J ^a   Jesudason, N ^a   Michie, K ^b   Winter, A J ^b   Gunson, R N ^a  

^a West of Scotland Specialist Virology Centre   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

Haematological; Hepatitis E; HIV

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ENZYME; HEPATITIS ANTIBODY; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; FEMALE; HEMATOLOGIC MALIGNANCY; HEPATITIS E; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRANSAMINASEMIA; LETTER; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; PATIENT MONITORING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEROPREVALENCE; UNITED KINGDOM; VIRUS LOAD; BLOOD; COHORT ANALYSIS; ENZYMOLOGY; LIVER; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE;

ADULT; COHORT STUDIES; ENZYMES; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS E; HUMANS; IMMUNOGLOBULIN G; LIVER; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; RNA, VIRAL; SCOTLAND;

EID: 84921260434     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.11.025     Document Type: Letter

References (8)

1. Hassing R.J., van der Eijk A.A., Baptista Lopes V., Snijdewind I.J., de Man R.A., Pas S.D., et al. Hepatitis E prevalence among HIV infected patients with elevated liver enzymes in the Netherlands. J Clin Virol 2014, 60(4):408-410.
2. Kaba M., Richet H., Ravaux I., Moreau J., Poizot-Martin I., Motte A., et al. Hepatitis E virus infection in patients infected with the human immunodeficiency virus. J Med Virol 2011, 83(10):1704-1716.
3. Renou C., Lafeuillade A., Cadranel J.F., Pavi N., Pariente A., Allègre T., et al. Hepatitis E virus in HIV-infected patients. AIDS 2010, 24:1493-1499.
4. Versluis J., Pas S.D., Agteresch H.J., de Man R.A., Maaskant J., Schipper M.E., et al. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood 2013, 122(6):1079-1086.
5. Kamar N., Abravanel F., Selves J., Garrouste C., Esposito L., Lavayssière L., et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 2010, 89(3):353-360.
6. BHIVA guidelines for the management of hepatitis viruses in adults infected with HIV 2013. HIV Med. 2013, 14(Suppl. 4):1-71. http://www.bhiva.org/documents/Guidelines/Hepatitis/2013/HepatitisGuidelines2013.pdf [accessed 25.09.14].
7. Jothikumar N., Cromeans T.L., Robertson B.H., Meng X.J., Hill V.R. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods 2006, 131:65-71.
8. Garson J.A., Ferns R.B., Grant P.R., Ijaz S., Nastouli E., Szypulska R., et al. Minor groove binder modification of widely used TaqMan probe for hepatitis E virus reduces risk of false negative real-time PCR results. J Virol Methods 2012, 186(1-2):157-160.